Ramsay (ASX:RHC) share price falls 6% amid reports of COVID battle plan

COVID-19 has imposed a major challenge on the private hospital operator.

| More on:
Graph showing a fall in share price.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Limited (ASX: RHC) share price is suffering today amid a broader market sell-off.

Meanwhile, reports have emerged that the private hospital operator has its sights set on a hiring spree, bringing in graduate nurses to fight against a COVID-19-exacerbated shortage.

At the time of writing, the Ramsay Health Care share price is $67.58, 5.76% lower than its previous close.

For context, the S&P/ASX 200 Index (ASX: XJO) has slumped 2.78% today, while the All Ordinaries Index (ASX: XAO) is down 2.83%.

Let's take a closer look at Ramsay's apparent plan to staff its hospitals through yet another COVID-19 outbreak.

Ramsay share price slides amid planned hiring spree

According to reporting by The Australian, Ramsay is planning to onboard its highest intake of graduate nurses to battle a shortage of staff made worse by the pandemic.

It expects to employ 550 new graduates – 25% more than it did during 2021.

Previous research by the federal government – conducted in 2014 – forecasts a shortfall of 85,000 nurses by 2025 and 123,000 by 2030.

On top of that, CEO of Ramsay's Australian operations, Carmel Monaghan was quoted as saying that the pandemic has worsened the shortage:

Like all industries, we see the workforce as our most significant challenge for the next few years. Supply has been constrained with borders closed and staff furloughed due to COVID.

Monaghan also stated that some nurses refused to be vaccinated against COVID-19, further exacerbating the shortage.

The Australian noted a shortage of nurses may block the company's hospitals from bouncing back to their full elective surgery capacity.

Elective surgeries are a major income source for Ramsay's private hospitals. In its results for financial year 2021, Ramsay reported that a 90-day restriction on elective surgeries in Victoria had a $70 million impact on the company's earnings before interest and tax.

Similar restrictions were put in place in New South Wales over the first half of financial year 2022 and were one reason behind a 39.5% fall in the company's unaudited net profit after tax for the first quarter of financial year 2022.

Thus, it likely goes without saying that the market will be watching the Ramsay Health Care share price when it releases its results for the first half of financial year 2022.

Monaghan reportedly told The Australian that the company has already received expressions of interest from 500 graduate nurses.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A doctor shrugs and holds his hands out.
Healthcare Shares

Down 36% in 2025, should you buy CSL shares today?

A leading investment expert offers his outlook for CSL’s beaten-down share price.

Read more »

Three guys in shirts and ties give the thumbs down.
Healthcare Shares

Why did Macquarie just downgrade CSL shares?

The broker has taken an axe to its valuation of this biotech giant.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Which drug company could pile on almost 30% in gains according to RBC Capital?

This drug company has plenty of irons in the fire, RBC Capital Markets says.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

This ASX 200 stock is charging higher on FDA approval news

This stock is avoiding the market weakness on Monday. Let's find out why.

Read more »

Doctor checking patient's spine x-ray image.
Healthcare Shares

Key Canadian approval sends 10-bagger biotech's shares higher

This 10-bagger company has just released more good news, with a breakthrough in the Canadian market.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

This biotech has lodged a key submission with US regulators

This company has lodged a key submission which will pave the way for sales of its heart failure software in…

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Here are the latest growth forecasts for the CSL share price

Let’s look at what experts are expecting from the healthcare giant in 2026.

Read more »

medical doctor performing surgery using surgical instruments
Healthcare Shares

Biotech company implants heart device in world first

This biotech company has implanted a heart device as part of a clinical trial looking to open up new markets.

Read more »